Boston, MA – The PharmaMarketing Summit 2026 is set to bring together the most influential minds in pharmaceutical marketing, taking place on September 17–18, 2026, at Encore Boston Harbor in Boston, Massachusetts. This exclusive, invitation-only summit will unite senior pharmaceutical marketing executives and innovative service providers, creating a high-impact platform for tackling the industry’s most pressing challenges and unlocking new commercial opportunities.
The summit features an exceptional line-up of speakers who are recognised leaders across the pharmaceutical landscape. Among them are:
- Michelle Melka, Sr. Director, BU Marketing Lead – Rare Disease, BioMarin Pharmaceutical Inc. Sharing strategies for building and scaling rare disease brands in an increasingly competitive market.
- Letitia Snyder, Vice President, Organized Customer Partnerships (Marketing), Pfizer Exploring how organised customer engagement models are reshaping pharmaceutical marketing at scale.
- Amol Luktuke, Head of US Hematology & Transplant Marketing and Rare Disease, Takeda Addressing the complexities of marketing across hematology, transplant, and rare disease portfolios in the US market.
- Rehan Baqri, Head of Marketing, US Oncology, Sanofi Discussing data-driven approaches to oncology marketing and how AI is transforming go-to-market execution.
- Vaibhav Priyam, Director, Marketing Sciences, Gilead Sciences Presenting cutting-edge applications of marketing sciences and analytics to drive measurable commercial impact.
These industry leaders will lead discussions on key topics shaping the future of pharmaceutical marketing, including AI and Machine Learning for Real ROI, Omnichannel HCP Engagement Best Practices, Rare Disease Brand Strategy and Niche Market Commercialization, Patient-Centric Marketing and the Empathy Economy, Data and Marketing Sciences in Drug Commercialization, Launch Excellence and Compliance-Ready Creativity, Oncology and Specialty Marketing Innovation, and Cross-Functional Collaboration for Commercial Success.
As the pharmaceutical industry faces mounting pressure to adapt to new technologies, evolving regulatory landscapes, and shifting patient expectations, the PharmaMarketing Summit 2026 is an essential event for those looking to stay ahead of the curve. Attendees will leave equipped with the actionable insights, strategic tools, and high-value connections needed to elevate their marketing strategies and drive measurable organisational impact.
For more information about the PharmaMarketing Summit 2026 or to request an invitation, please visit the summit website or contact Christophoros Ioannou at christophorosi@marcusevanscy.com.